Related references
Note: Only part of the references are listed.Patient-Defined Treatment Success: Perspectives of Patients With Advanced-Stage Lung Cancer
K. M. Islam et al.
JOURNAL OF ONCOLOGY PRACTICE (2019)
Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer
K. M. Islam et al.
BMC CANCER (2019)
The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer A Systematic Review and Qualitative Assessment of the Literature
Michael J. Raphael et al.
JAMA ONCOLOGY (2019)
Analysis of patient and nurse preferences for self-administered FSH injection devices in select European markets
Pierre Zitoun et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2019)
Lay Summaries of Clinical Study Results: An Overview
Amber Barnes et al.
PHARMACEUTICAL MEDICINE (2019)
A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer
Michelle K. Wilson et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer
Andrew D. Seidman et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
A critical evaluation of quality of life in clinical trials of breast cancer patients treated with radiation therapy
Gustavo N. Marta et al.
ANNALS OF PALLIATIVE MEDICINE (2017)
Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms
Paul G. Kluetz et al.
CLINICAL CANCER RESEARCH (2016)
Endpoints in clinical trials: What do patients consider important? A survey of the Ovarian Cancer National Alliance
Lindsey E. Minion et al.
GYNECOLOGIC ONCOLOGY (2016)
Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey
Phillip Ertel et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2016)
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
Andrew Bottomley et al.
LANCET ONCOLOGY (2016)
Creating clinical trial designs that incorporate clinical outcome assessments
Mark R. Gilbert et al.
NEURO-ONCOLOGY (2016)
Patients' willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey
Sing Yu Moorcraft et al.
TRIALS (2016)
Experimental measurement of preferences in health care using best-worst scaling (BWS): theoretical and statistical issues
Axel C. Muehlbacher et al.
HEALTH ECONOMICS REVIEW (2016)
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
S. Gourgou-Bourgade et al.
ANNALS OF ONCOLOGY (2015)
Sharing Clinical Trial Data Maximizing Benefits, Minimizing Risk
Bernard Lo
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Outcomes and endpoints in trials of cancer treatment: the past, present, and future
Michelle K. Wilson et al.
LANCET ONCOLOGY (2015)
Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review Perspectives From Industry, the Food and Drug Administration, and the Patient
Ethan Basch et al.
JAMA ONCOLOGY (2015)
Examining and predicting drug preferences of patients with metastatic breast cancer: using conjoint analysis to examine attributes of paclitaxel and capecitabine
Mary Lou Smith et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
American Society of Clinical Oncology Perspective: Raising the Bar for Clinical Trials by Defining Clinically Meaningful Outcomes
Lee M. Ellis et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment Trials
Bryce B. Reeve et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Endpoints in cancer clinical trials
F. Fiteni et al.
JOURNAL OF VISCERAL SURGERY (2014)
Relative influence of factors determining a woman's preference for treatment options in ovarian cancer.
Laura Jean Havrilesky et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Patients' understanding of medical terminology used in the breast clinic
R. L. O'Connell et al.
BREAST (2013)
Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer
Sara A. Hurvitz et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Recommendations for including multiple symptoms as endpoints in cancer clinical trials
Charles S. Cleeland et al.
CANCER (2013)
The use and reporting of patient-reported outcomes in phase III breast cancer trials
Remy L. Brim et al.
CLINICAL TRIALS (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
Jane C. Weeks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Meeting the obligation to communicate clinical trial results to study volunteers
Kenneth Getz et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
Factors affecting residency rank-listing: A Maxdiff survey of graduating Canadian medical students
Tao Wang et al.
BMC MEDICAL EDUCATION (2011)
The Role of the US Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology
Amy E. McKee et al.
ONCOLOGIST (2010)
Estimating preferences for a dermatology consultation using Best-Worst Scaling: Comparison of various methods of analysis
Terry N. Flynn et al.
BMC MEDICAL RESEARCH METHODOLOGY (2008)
Managing conflicts of interest in the conduct of clinical trials
K Morin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The industrialization of clinical research
RA Rettig
HEALTH AFFAIRS (2000)
Share Paper
